W
Wendy Kampman
Researcher at Regeneron
Publications - 8
Citations - 1467
Wendy Kampman is an academic researcher from Regeneron. The author has contributed to research in topics: Viral load & Placebo. The author has an hindex of 5, co-authored 8 publications receiving 620 citations.
Papers
More filters
Journal ArticleDOI
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19.
David M. Weinreich,Sumathi Sivapalasingam,Thomas Norton,Shazia Ali,Haitao Gao,Rafia Bhore,Bret J Musser,Yuhwen Soo,Diana Rofail,Joseph Im,Christina Perry,Cynthia Pan,Romana Hosain,Adnan Mahmood,John D. Davis,Kenneth C. Turner,Andrea T. Hooper,Jennifer D. Hamilton,Alina Baum,Christos A. Kyratsous,Yunji Kim,Amanda Cook,Wendy Kampman,Anita Kohli,Yessica Sachdeva,Ximena Graber,Bari Kowal,Thomas DiCioccio,Neil Stahl,Leah Lipsich,Ned Braunstein,Gary Herman,George D. Yancopoulos +32 more
TL;DR: In this interim analysis, the REGN-COV2 antibody cocktail reduced viral load, with a greater effect in patients whose immune response had not yet been initiated or who had a high viral load at baseline.
Posted ContentDOI
REGEN-COV Antibody Cocktail Clinical Outcomes Study in Covid-19 Outpatients
David M. Weinreich,Sumathi Sivapalasingam,Thomas Norton,Shazia Ali,Haitao Gao,Rafia Bhore,Jing Xiao,Andrea T. Hooper,Jennifer D. Hamilton,Bret J Musser,Diana Rofail,Mohamed Hussein,Joseph Im,Dominique Y Atmodjo,Christina Perry,Cynthia Pan,Adnan Mahmood,Romana Hosain,John D. Davis,Kenneth C. Turner,Alina Baum,Christos A. Kyratsous,Yunji Kim,Amanda Cook,Wendy Kampman,Lilia Roque-Guerrero,Gerard Acloque,Hessam Aazami,Kevin Cannon,J. Abraham Simon-Campos,Joseph A. Bocchini,Bari Kowal,Thomas DiCioccio,Yuhwen Soo,Neil Stahl,Leah Lipsich,Ned Braunstein,Gary Herman,George D. Yancopoulos,Trial Investigators +39 more
TL;DR: Regen-COV has been shown to significantly reduce Covid-19-related hospitalization or all-cause death, rapidly resolved symptoms, and reduced viral load as discussed by the authors.
Posted ContentDOI
REGEN-COV Antibody Cocktail in Outpatients with Covid-19
David M. Weinreich,Sumathi Sivapalasingam,Thomas Norton,Shazia Ali,Haitao Gao,Rafia Bhore,Andrea T. Hooper,Jennifer D. Hamilton,Bret J Musser,Yuhwen Soo,Diana Rofail,Joseph Im,Christina Perry,Cynthia Pan,Romana Hosain,Adnan Mahmood,John D. Davis,Kenneth C. Turner,Alina Baum,Christos A. Kyratsous,Yunji Kim,Amanda Cook,Wendy Kampman,Ximena Graber,Gerard Acloque,Yessica Sachdeva,Joseph A. Bocchini,Anita Kohli,Bari Kowal,Thomas DiCioccio,Neil Stahl,Leah Lipsich,Ned Braunstein,Gary Herman,George D. Yancopoulos +34 more
TL;DR: REGEN-COV treatment of outpatients significantly reduced SARS-CoV-2 viral load and Covid-19-related medically-attended visits and safety was similar across groups.
Posted ContentDOI
A Randomized Placebo-Controlled Trial of Sarilumab in Hospitalized Patients with Covid-19
Sumathi Sivapalasingam,D.J. Lederer,Rafia Bhore,Negin Hajizadeh,Gerard J. Criner,Romana Hosain,Adnan Mahmood,Angeliki Giannelou,Selin Somersan-Karakaya,Meagan P. O'Brien,Anita Boyapati,Janie Parrino,Bret J Musser,Emily Labriola-Tompkins,Divya Ramesh,Lisa A. Purcell,Daya Gulabani,Wendy Kampman,Alpana Waldron,Michelle N. Gong,Suraj Saggar,Steven J. Sperber,Vidya Menon,David Stein,Magdalena E. Sobieszczyk,William Park,Judith A. Aberg,Samuel M. Brown,Jack A. Kosmicki,Julie E. Horowitz,Manuel A. R. Ferreira,Aris Baras,Bari Kowal,A. Thomas DiCioccio,Bolanle Akinlade,Michael C Nivens,Ned Braunstein,Gary Herman,George D. Yancopoulos,David M. Weinreich,Sarilumab-COVID Study Team +40 more
TL;DR: In this article, the authors performed an adaptive, phase 2/3, randomized, double-blind, placebo-controlled trial of intravenous sarilumab 200 mg or 400 mg in adults hospitalized with Covid-19.
Journal ArticleDOI
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19.
David M. Weinreich,Sumathi Sivapalasingam,Thomas T. Norton,Shazia Ali,Haitao Gao,Rafia Bhore,Jing Xiao,Andrea T. Hooper,Jennifer D. Hamilton,Bret J. Musser,Diana Rofail,Mohamed Hussein,Joseph Im,Dominique Y Atmodjo,Christina Perry,Cynthia Pan,Adnan Mahmood,Romana Hosain,John D. Davis,Kenneth C. Turner,Alina Baum,Christos A. Kyratsous,Yunji Kim,Amanda Cook,Wendy Kampman,Lilia Roque-Guerrero,Gerard Acloque,Hessam Aazami,Kevin Cannon,J. Abraham Simon-Campos,Joseph A. Bocchini,Bari Kowal,A. Thomas DiCioccio,Yuhwen Soo,Gregory P. Geba,Neil Stahl,Leah Lipsich,Ned Braunstein,G. Herman,George D. Yancopoulos +39 more
TL;DR: In the phase 3 portion of an adaptive trial, the authors randomly assigned outpatients with Covid-19 and risk factors for severe disease to receive various doses of intravenous REGEN-COV or placebo.